StockTipsArenaBeta

BUY Glenmark Pharmaceuticals — Prakash Gaba

BUYGlenmark Pharmaceuticals

byPrakash GabaHorizon: NA (inferred Swing (≤2wk))17 Aug 2026via CNBC Awaaz.

Entry₹2,329.7Inferred
Target₹2,400
Total upside +3.02% (call closed)
Stop loss₹2,325-0.20% risk
Exit₹2,32517 Aug 2026, 9:20 am
Stop-loss hit-0.20%
Follow Prakash Gaba for new calls(28% target hit, 188 closed calls)Get alertsWatch GLENMARK for new buy/sell callsGet alertsSee 116 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 17 Aug 2026
4 supporting3 neutral1 opposing
Supports the BUY call (4)

3 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·14 Aug · 2d ago

4 advisors have active short-term BUY calls on this stock, with 2 issued in the last 14 days

Advisor consensus · adjacent horizon·11 Aug · 6d ago

Glenmark Pharma Q1 Revenue Beats Estimates, EBITDA Margins Seen Rising

NewsGoogle News·4 Aug · 2w ago

(opens in new tab)

Glenmark Pharma's India-US Growth Story Intact, Says Motilal Oswal, Maintaining 'Buy' — Check Target Price

NewsNdtv-Profit·4 Aug · 2w ago

(opens in new tab)
Neutral / worth noting (3)

Glenmark USA has agreed to a settlement of $15.28 million to resolve antitrust and consumer protection lawsuits related to price-fixing allegations. The company denies all allegations and states the s

BSE · Company Update·11 Aug · 5d ago

(opens in new tab)

Glenmark Pharma Q1 FY27 Results and Brokerage Outlook

NewsGoogle News·4 Aug · 2w ago

(opens in new tab)

Stock Picks Today: Glenmark Pharma, United Spirits, Kansai Nerolac, UPL, Exide And More On Brokerages' Radar

NewsNdtv-Profit·4 Aug · 2w ago

(opens in new tab)
Weighs against the BUY call (1)

Glenmark Pharma US arm agrees to $15.28 million settlement with Humana over antitrust lawsuits

NewsCnbc-Tv18·12 Aug · 5d ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.